Both in Pharmaceuticals
Schrodinger vs Sarepta Therapeutics,
Over the past year SDGR returned +42.7% and SRPT returned +17.2%; their daily moves had a correlation of 0.27.
SDGR +42.7% SRPT +17.2%Growth of $1, one year, split-adjusted
| Metric | SDGR | SRPT |
|---|---|---|
| Price | $28.52 | $18.99 |
| Market cap | $2.13B | $2.01B |
| Today | +4.93% | +2.43% |
| 1 month | −1.3% | +9.7% |
| 6 months | +119.7% | −17.5% |
| Year to date | +59.5% | −11.8% |
| 1 year | +38.8% | −22.3% |
| Revenue growth (YoY) | +7.5% | −34.3% |
| Gross margin | 55.1% | 62.8% |
| Net margin | 10.1% | −1.2% |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | 1.0× |
| Net cash | $413.7M | -$59.1M |
| Dividend yield | — | — |
| Volatility (60d) | 94.5% | 61.6% |
| Short % of float | 19.8% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).